학술논문

Leflunomide-Induced Interstitial Lung Disease: A Case Report.
Document Type
Article
Source
Eurasian Journal of Pulmonology. 2015, Vol. 17 Issue 1, p67-69. 3p.
Subject
*LUNG disease diagnosis
*LEFLUNOMIDE
*COMPUTED tomography
*PULMONARY fibrosis
*CHEST X rays
Language
ISSN
2148-3620
Abstract
Leflunomide (LEF) induced interstitial pneumonitis is a very rare condition but potentially fatal. We report a case of LEF induced interstitial pneumonitis. A 63-year-old woman followed-up for 37 years with the diagnosis of rheumatoid arthritis treated with LEF (20 mg/day) since 5 months were admitted to our hospital with cough, dyspnea, fever, and dark sputum. Chest radiography represented bilateral alveolar consolidation. High-resolution computed tomography demonstrated diffuse ground-glass appearance and interlobular septal thickening. Since the patient's clinics and radiologic findings improved dramatically after the cessation of LEF and recieving oral steriod therapy, she was diagnosed as drug-induced interstitial lung disease. In conclusion, when nonspecific clinical signs such as respiratory distress, cough and fever seen during the use of LEF, drug-induced interstitial lung disease should be kept in mind for the differantial diagnosis. [ABSTRACT FROM AUTHOR]